A Humanized CB1R Yeast Biosensor Enables Facile Screening of Cannabinoid Compounds

Colleen J. Mulvihill,Joshua D. Lutgens,Jimmy D. Gollihar,Petra Bachanová,Caitlin Tramont,Edward M. Marcotte,Andrew D. Ellington,Elizabeth C. Gardner

DOI: https://doi.org/10.3390/ijms25116060

IF: 5.6

2024-05-31

International Journal of Molecular Sciences

Abstract:Yeast expression of human G-protein-coupled receptors (GPCRs) can be used as a biosensor platform for the detection of pharmaceuticals. Cannabinoid receptor type 1 (CB1R) is of particular interest, given the cornucopia of natural and synthetic cannabinoids being explored as therapeutics. We show for the first time that engineering the N-terminus of CB1R allows for efficient signal transduction in yeast, and that engineering the sterol composition of the yeast membrane modulates its performance. Using an engineered cannabinoid biosensor, we demonstrate that large libraries of synthetic cannabinoids and terpenes can be quickly screened to elucidate known and novel structure–activity relationships. The biosensor strains offer a ready platform for evaluating the activity of new synthetic cannabinoids, monitoring drugs of abuse, and developing therapeutic molecules.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to develop an efficient humanized CB1R yeast biosensor for rapid screening of cannabinoid compounds. Specifically, the researchers hope to overcome the challenges of expressing human G - protein - coupled receptors (GPCRs), especially CB1R, in yeast. By optimizing the signal transduction efficiency and membrane composition of the receptor, this biosensor can effectively detect and distinguish the activities of different cannabinoid compounds, thereby accelerating the research and development of new cannabinoid drugs and providing a tool for monitoring drug abuse.

### Main problems solved in the paper:

1. **Functional expression of CB1R in yeast**:
- Improve the signal transduction efficiency of CB1R in yeast by engineering the N - terminal domain of CB1R and optimizing the sterol composition of the yeast membrane.
- Use the fluorescent reporter gene ZsGreen to detect the activation of CB1R, thereby achieving high - throughput screening of cannabinoid compounds.

2. **Optimization of the yeast sterol environment**:
- Study the effects of different sterols (such as cholesterol and its precursors) on CB1R activity, and find that the natural yeast sterol (ergosterol) promotes CB1R signal transduction better than cholesterol and its precursors.
- By changing the sterol synthesis pathway of yeast, a series of yeast strains with different sterol compositions are created to optimize the activity of CB1R.

3. **High - throughput drug screening**:
- Use the optimized CB1R yeast biosensor to conduct high - throughput screening on more than 300 synthetic cannabinoids and more than 30 terpenoid compounds to identify their activation or inhibition effects on CB1R.
- Through dose - response experiments, determine the EC50 values of multiple known and unknown cannabinoid compounds, revealing their structure - activity relationships.

4. **Verification of screening results**:
- Verify the reliability and sensitivity of the yeast biosensor by retesting some of the screened compounds in mammalian cells.
- It is found that the sensitivity of the yeast biosensor to cannabinoid agonists is much higher than that of mammalian cells, which provides a powerful tool for future drug research and development.

### Summary:
This study successfully developed an efficient humanized CB1R yeast biosensor by engineering CB1R and optimizing the sterol composition of the yeast membrane. This tool can not only rapidly screen a large number of cannabinoid compounds, but also reveal new structure - activity relationships, providing important technical support for the research and development of new cannabinoid drugs and the monitoring of drug abuse.